897043-85-5

Basic information

• Product Name: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester
• Synonyms: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester;3-Methyl-4-oxo-pyrrolidine-1,3-dicarboxylic acid-1-tert-butyl ester-3-ethyl ester;Ethyl 1-Boc-3-methyl-4-oxopyrrolidine-3-carboxylate
• CAS NO: 897043-85-5
• Molecular Formula: C₁₃H₂₁NO₅
• Molecular Weight: 272.31748
• Mol File: 897043-85-5.mol

Chemical Properties

• Appearance: /
• Density: 1.149
• CAS DataBase Reference: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester(897043-85-5)
• EPA Substance Registry System: 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester(897043-85-5)

Safety Data

• Hazardous Substances Data: 897043-85-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester is used as a key building block for the synthesis of various drugs and pharmaceutical compounds. Its unique structure and reactivity make it a valuable component in the development of new medications and therapeutic agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester is utilized as a versatile intermediate for the creation of novel chemical entities. Its properties allow for the exploration of new drug candidates with potential therapeutic benefits.
Used in Drug Discovery:
3-Methyl-4-oxo-1,3-pyrrolidinedicarboxylic acid 1-(tert-butyl) 3-ethyl ester plays a significant role in drug discovery, where it is employed as a starting material for the design and synthesis of innovative pharmaceuticals. Its potential applications in this area highlight its importance in advancing the development of new treatments and therapies.

Upstream product

• 146256-98-6 4-oxo-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester 3-ethyl ester 
• 74-88-4 methyl iodide 
• 14719-37-0 ethyl 2-(tert-butoxycarbonylamino)acetate 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

Novel stereoselective synthesis of all four diastereomers of 3a-methyl-pyrrolo[3,4-c]piperidine from glycine ethyl ester

Asymmetric synthesis of all four diastereomers of 3a-methyl-pyrrolo[3,4-c]piperidine is described herein. The key steps in this synthesis are the highly diastereoselective hydrogenation of an alkenyl nitrile through a hydroxyl-directed or sterically contr

ALKYNYL QUINAZOLINE COMPOUNDS

The present disclosure relates to compounds of Formula (I'): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparation these compounds, compositions comprising these compounds, and methods of using them in the prevention or treatment of abnormal cell growth in mammals, especially humans.

CYCLIC COMPOUNDS AND METHODS OF USING SAME

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.

BICYCLIC AMINES AS NOVEL JAK KINASE INHIBITORS

The present invention relates to a compound according to formula (I) wherein R1 represents alkyl; n is 1 or 2; R2 is selected from the group consisting of hydrogen, cyano, -SO2Ra, -SO2NRbR

Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety

A series of novel fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety were designed, synthesized and evaluated for their biological activity. Our results revealed that 19b2 shows good activity against MTB H

PYRROLIDYL DERIVATIVES OF HETEROAROMATIC COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS

The invention pertains to new pyrrolidyl derivatives of benzo-fused aza heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. The invention also relates to compounds that are selective inhibitors of PDE-IO. The invention fur